Allelic drop-out in the LDLR gene affects mutation detection in familial hypercholesterolemia

Clinical Biochemistry

Volumn 41, Issue 1-2, 2008, Pages 38-40

  Laios, Eleftheria ^a   Glynou, Kyriaki ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Medicon SA   (Greece)

Author keywords

Greece; Hypercholesterolemia; Low density lipoprotein receptor; Mutation

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; DNA MUTATIONAL ANALYSIS; FALSE POSITIVE REACTIONS; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LINKAGE DISEQUILIBRIUM; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LDL; RESEARCH DESIGN;

EID: 36849078874     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.09.017     Document Type: Article

References (10)

1. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. vol. II (1995), McGraw Hill, New York 1981-2030
2. Laios E., and Drogari E. Analysis of LDLR mutations in familial hypercholesterolemia patients in Greece by use of the NanoChip microelectronic array technology. Clin Chim Acta 374 1-2 (2006) 93-99
3. Allard D., Amsellem S., Abifadel M., et al. Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia. Hum Mutat 26 5 (2005) 497 (Erratum in: Hum Mutat 2005;26(6):592)
4. Humphries S.E., Whittall R.A., Hubbart C.S., et al. Genetic causes of familial hypercholesterolemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet 43 12 (2006) 943-949
5. Ellard S., Bulman M.P., Frayling T.M., Allen L.I.S., Dronsfield M.J., Tack C.J., et al. Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1a gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes 48 (1999) 921-923
6. Zajickova K., Krepelova A., and Zofkova I. A single nucleotide polymorphism under the reverse primer binding site may lead to BsmI mis-genotyping in the vitamin D receptor gene. J Bone Miner Res 18 10 (2003) 1754-1757
7. Heinrich M., Müller M., Rand S., Brinkmann B., and Hohoff C. Allelic drop-out in the STR system ACTBP2 (SE33) as a result of mutations in the primer binding region. Int J Legal Med 1189 (2004) 361-363
8. Ward K.J., Ellard S., Yajnik C.S., Frayling T.M., Hattersley A., and Venigalla P.N.S. Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the - 1131T > C polymorphism of the Apolipoprotein AV gene. Lipids Health Dis 5 (2006) 11-16
9. Hobbs H.H., Brown M.S., and Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolaemia. Hum Mutat 1 (1992) 445-466
10. Nissen H., Guldberg P., Hansen A.B., Petersen N.E., and Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 8 (1996) 168-177